1 - 2 of
2 for companies in category
Biomaterials in
Canada:
The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.
The Company's lead product in development is a passive, nano-film Hydroxyapatite (HAp) coating. In parallel, the Company is developing a multi-layer nano-film coating with drug-eluting capabilities to facilitate therapeutics and treatments for localized drug delivery systems.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
